Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antidepressant treatment and side effect considerations.

G D Tollefson1

  • 1Department of Psychiatry, St. Paul-Ramsey Medical Center, Minn 57101.

The Journal of Clinical Psychiatry
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of schizophrenic disorders: Algorithms for acute pharmacotherapy.

International journal of psychiatry in clinical practice·2014
Same author

The double-blind variable placebo lead-in period: results from two antidepressant clinical trials.

Journal of clinical psychopharmacology·2002
Same author

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.

The Journal of clinical psychiatry·2001
Same author

Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.

The Journal of clinical psychiatry·2001
Same author

Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone.

The Journal of clinical psychiatry·2001
Same author

Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine.

Biological psychiatry·2001

Choosing the right antidepressant involves balancing efficacy with side effect profiles. A patient

Area of Science:

  • Pharmacology
  • Psychiatry
  • Clinical Therapeutics

Background:

  • A wide array of antidepressant medications exist, categorized into first-generation and second-generation drugs.
  • While many antidepressants share similar efficacy, onset of action, and treatment response latency, their side effect and toxicity profiles vary significantly.

Purpose of the Study:

  • To highlight the importance of considering individual patient profiles when selecting antidepressant therapy.
  • To emphasize the need to weigh clinical effectiveness against potential negative side effects and toxicity.

Main Methods:

  • Reviewing the efficacy, onset, and latency of antidepressant drug classes.
  • Analyzing the differential side effect and toxicity profiles of various antidepressants.
  • Assessing patient-specific risk factors through medical history and concurrent drug therapies.

Related Experiment Videos

Main Results:

  • Antidepressant drugs exhibit diverse side effect and toxicity profiles despite comparable efficacy.
  • Patient medical history and concomitant drug therapies are crucial for identifying at-risk individuals for adverse drug effects.
  • A careful review of the relative toxicity index of antidepressants is essential for safe prescribing.

Conclusions:

  • Prescribing the most beneficial antidepressant requires balancing clinical effectiveness with minimal adverse effects.
  • Personalized risk assessment, considering medical history and drug interactions, is vital for optimizing antidepressant selection.
  • Understanding and utilizing the relative toxicity index aids in preventing negative sequelae of antidepressant treatment.